A Phase II, Multicenter, Randomized, Double Blind, Vehicle Controlled Study Evaluating the Efficacy and Tolerability of AS101 15% Gel for External Genital Warts

Trial Profile

A Phase II, Multicenter, Randomized, Double Blind, Vehicle Controlled Study Evaluating the Efficacy and Tolerability of AS101 15% Gel for External Genital Warts

Recruiting
Phase of Trial: Phase II

Latest Information Update: 21 Jul 2017

At a glance

  • Drugs AS 101 (Primary)
  • Indications Genital warts
  • Focus Proof of concept; Therapeutic Use
  • Sponsors BioMAS
  • Most Recent Events

    • 21 Jul 2017 According to a Cassiopea media release, 73% of the total enrollment has been completed in the trial.
    • 31 Oct 2016 Planned End Date changed from 1 Jan 2016 to 1 May 2017.
    • 31 Oct 2016 Planned primary completion date changed from 1 Jan 2016 to 1 May 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top